Hematologic Toxicity

ToxicityGrade 2Grade 3Grade 4
LeukocytopeniaNo therapeutic relevance00
AnemiaNo therapeutic relevance00
  • * Toxicity after first cycle; second cycle postponed.

  • In 2 patients, persistent after first cycle, no further therapy possible. One patient had extensive bone metastases and grade 2 thrombocytopenia after regular therapy; other patients had long-lasting myelosuppression after regular therapy and again after additional therapy despite reduced dose of 3.7 GBq.

  • Toxicity after second cycle.